Rocket Lab Stock: $30 Retest Possible?
- Rocket Lab USA, Inc.(RKLB) received a boost from Cantor Fitzgerald, which increased its primary_keyword price target to $35, citing the company's strategic advancements and strong pipeline.
- The anticipation surrounding the Neutron rocket's maiden flight, scheduled for the second half of 2025, is also fueling positive sentiment.
- Cantor Fitzgerald also highlighted Rocket Lab's competitive position against SpaceX and potential benefits from U.S.
Fuel your investment strategy! Analyst optimism surrounds Rocket Lab, with Cantor Fitzgerald boosting the primary_keyword price target to $35, signaling significant growth potential.Shares are currently trading above $25,and a possible retest of $30 is on the cards before a potential breakout. The upcoming Neutron rocket test flight in late 2025 is generating buzz, enhancing investor confidence in the secondary_keyword commercial space sector.News Directory 3 delivers the latest insights into Rocket Lab’s strategic advancements, including new Electron launch missions-showcasing their dedication as a leading player, competitive against SpaceX, and positioned for major government contracts. With strong ratings from multiple analysts, the future looks radiant. Discover what’s next for this aerospace innovator.
Rocket Lab Stock Target Boosted; Analyst Sees Double-Digit Upside
Updated june 21, 2025
Rocket Lab USA, Inc.(RKLB) received a boost from Cantor Fitzgerald, which increased its primary_keyword price target to $35, citing the company’s strategic advancements and strong pipeline. The aerospace and defense firm’s shares are currently consolidating above $25, with analysts suggesting a retest of $30 could precede a breakout.
The anticipation surrounding the Neutron rocket’s maiden flight, scheduled for the second half of 2025, is also fueling positive sentiment. Cantor Fitzgerald reaffirmed its “Overweight” rating for Rocket Lab on June 10, raising the target from $29. The firm’s optimism stems from Rocket Lab’s growth prospects in the commercial space sector, its track record of 66 triumphant launches, and acquisitions like Mynaric and Geost, which enhance its end-to-end space systems.
Cantor Fitzgerald also highlighted Rocket Lab’s competitive position against SpaceX and potential benefits from U.S. government initiatives. The $35 target reflects confidence in Rocket Lab’s ability to leverage its $1.07 billion backlog and projected revenue growth of 31-33% in fiscal year 2025.
Other analysts share this positive outlook. of 13 ratings, one is a “Strong Buy,” seven are “Buy,” and five are “Hold.” The consensus price target stands at $28.10, suggesting further upside. Roth Capital also holds a street-high target of $35.
While the Neutron rocket garners attention, Rocket Lab’s Electron vehicle continues to be a reliable launch solution. On June 16, the company announced two dedicated missions for a confidential commercial customer.The first, “Symphony In The Stars,” is scheduled for June 20 from Launch Complex 1 in New Zealand, placing a satellite into a 650km circular orbit. A second, similar mission will launch before year’s end. These missions highlight Rocket Lab’s dedicated small launch market leadership.
“These newly added missions highlight Electron’s strengths,rapid turnaround,dedicated access,and versatility for satellite operators,” said Rocket Lab CEO Peter Beck.
With over 20 missions planned for 2025 and a perfect success rate this year, Electron supports Rocket Lab’s expansion across its New Zealand and Virginia launch sites, serving commercial, civil, and government clients. This positions Rocket Lab as a key player in the commercial space sector, offering diverse launch solutions and end-to-end space systems.
What’s next
Rocket Lab will continue to focus on its Electron launches while preparing for the first test flight of its Neutron rocket in late 2025, aiming to further solidify its position in the growing commercial space sector and capitalize on government space initiatives.